Call us: +44 870 8 200 310
Or write: experts@regartis.com
germ cell mutagenicity
| Page | Keyword count |
| TITLE VII: AUTHORISATION | |
| CHAPTER 1: Authorisation requirement | |
| Article 57: Substances to be included in Annex XIV | 1 |
| TITLE VIII: RESTRICTIONS ON THE MANUFACTURING, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, MIXTURES AND ARTICLES | |
| CHAPTER 2: Restrictions process | |
| Article 68: Introducing new and amending current restrictions | 1 |
| TITLE XV: TRANSITIONAL AND FINAL PROVISIONS | |
| Article 138: Review | 1 |
| ANNEX I: GENERAL PROVISIONS FOR ASSESSING SUBSTANCES AND PREPARING CHEMICAL SAFETY REPORTS | |
| 1.: HUMAN HEALTH HAZARD ASSESSMENT | |
| 1.0.: Introduction | 1 |
| 1.3.: Step 3: Classification and Labelling | 1 |
| 1.4.: Step 4: Identification of DNEL(s) | 1 |
| ANNEX II: REQUIREMENTS FOR THE COMPILATION OF SAFETY DATA SHEETS | |
| 11.: SECTION 11: Toxicological information | |
| 11.1.: Information on toxicological effects | 1 |
| ANNEX III: CRITERIA FOR SUBSTANCES REGISTERED IN QUANTITIES BETWEEN 1 AND 10 TONNES | 1 |
| ANNEX IX: STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 100 TONNES OR MORE | |
| 8.: TOXICOLOGICAL INFORMATION | 2 |
| ANNEX X: STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF 1 000 TONNES OR MORE | |
| 8.: TOXICOLOGICAL INFORMATION | 2 |